P381: Factors predicting risk of colectomy in patients receiving first line steroid and second line biologic salvage therapy for Acute Severe Ulcerative ColitisECCO'22Year: 2022
Authors: Skinezes, Y.(1,2);Meir, Z.Y.(1,2);Abitbol, C.M.(1,2);Levartovsky, A.(1,2);Klang, E.(1,2);Kopylov, U.(1,2);Ben-Horin, S.(1,2);Ungar, B.(1,2);
(1)Sheba medical center- Tel Hashomer, Gastroenterology, Ramat Gan, Israel;(2)Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel;
P383: Ustekinumab as an opportunity for refractory Ulcerative Colitis patients.ECCO'22Year: 2022
Authors: Iborra, M.(1);Soutullo, C.(1);Gimeno, M.(1);Bastida, G.(1);Aguas, M.(1);Cerrillo, E.(1);Sáez-González, E.(1);Garrido, A.(1);Mínguez, A.(1);Bordetas, J.(1);Nos, P.(1);
(1)Hospital Universitario y Politécnico La Fe, Gastroenterology Department, Valencia, Spain;
P384: Postoperative Endoscopic Recurrence In Patients With Crohn’s Disease After “Curative” Ileocecal Resection on Prophylaxis Treatment With Either Anti-TNFs, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyECCO'22Year: 2022
Authors: Yanai, H.(1,2);Amir Barak , H.(1,2);Kagramanova, A.(3);Knyazev , O.(3);Sabino, J.(4);Haenen, S.(4);Mantzaris , G.J.(5);Mountaki, K.(5);Pugliese, D.(6);Armuzzi, A.(6,7);Furfaro, F.(8);Fiorino, G.(8);Drobne, D.(9,10);Kurent, T.(10);Yassin, S.(2,11);Maharshak, N.(2,11);Castiglione, F.(12);Nardone, O.M.(12);de Sire, R.(12);Farkas, K.(13);Molnar, T.(13);Krznaric, Z.(14);Brinar, M.(14);Chashkova, E.(15);Margolin, M.L.(2,16);Kopylov, U.(2,16);Bezzio, C.(17);Bar-Gil Shitrit, A.(18);Lukas , M.(19,20);Chaparro, M.(21);Truyens, M.(22,23);Nancey, S.(24);Revés, J.(25);Avni-Biron, I.(1,2);Ollech, J.E.(1,2);Dotan, I.(1,2);Aharoni Golan, M.(1,2);
(1)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(2)Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel;(3)Moscow Clinical Scientific Centre n.a. A.S. Loginov, IBD department, Moscow, Russian Federation;(4)University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium;(5)GHA 'Eveggelismos-Polykliniki', Department of Gastroenterology, Athens, Greece;(6)Fondazione Policlinico Universitario @A. Gemelli@ IRCCS, CEMAD- Inflammatory Bowel Disease Unit- Unità Operativa Complessa di Medicina Interna e Gastroenterologia- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(7)Università Cattolica del Sacro Cuore, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Rome, Italy;(8)Humanitas Clinical and Research Center – IRCCS, IBD Unit- Rozzano, Milan, Italy;(9)University Medical Centre Ljubljana, Department of Gastroenterology, Ljubljana, Slovenia;(10)University of Ljubljana, Medical Faculty, Ljubljana, Slovenia;(11)Tel Aviv Medical Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(12)University of Naples Federico II, Department of Clinical Medicine and Surgery, Naples, Italy;(13)University of Szeged, Department of Medicine, Szeged, Hungary;(14)University Hospital Centre, Department of Gastroenterology- Hepatology and Nutrition, Zagreb, Croatia;(15)Irkutsk Scientific Center of Surgery and Traumatology, Department of Reconstructive Surgery, Irkutsk, Russian Federation;(16)Sheba medical center, Gastroenterology department, Tel Hashomer, Israel;(17)Rho Hospital, Gastroenterology Unit- Asst Rhodense, Milano, Italy;(18)Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel;(19)ISCARE Clinical Centre, Clinical and Research Centre for Inflammatory Bowel Disease, Prague, Czech Republic;(20)General University Hospital and First Faculty of Medicine- Charles University, Institute of Medical Biochemistry and Laboratory Medicine, Prague, Czech Republic;(21)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Madrid, Spain;(22)University Hospital Ghent, IBD unit-Department of Gastroenterology, Ghent, Belgium;(23)Ghent University, Department of Internal Medicine and Pediatrics, Ghent, Belgium;(24)Lyon-Sud hospital- Hospices Civils de Lyon, Department of Gastroenterology, Lyon, France;(25)Hospital Beatriz Ângelo- Loures, Gastroenterology Division, Lisbon, Portugal;
P385: Tailoring induction treatment for children with Crohn’s disease.ECCO'22Year: 2022
Authors: Cuomo, M.(1);Carobbio, A.(2);Aloi , M.(3);Alvisi , P.(4);Banzato, C.(5);Bosa, L.(6);Bramuzzo, M.(7);Campanozzi, A.(8);Catassi , G.(3);D'Antiga, L.(2);Di Paola, M.(9);Felici, E.(10);Fioretti , M.T.(11);Gatti , S.(12);Graziano, F.(13);Lega , S.(7);Lionetti , P.(9);Marseglia , A.(14);Martinelli , M.(11);Musto, F.(15);Sansotta, N.(2);Scarallo , L.(9);Zuin, G.(15);Norsa, L.(16);
(1)San Carlo Hospital - ASST Santi Paolo e Carlo, Department of Paediatric, Milano, Italy;(2)ASST Papa Giovanni XXIII, FROM Research foundation, Bergamo, Italy;(3)Sapienza University of Rome, Paediatric Gastroenterology and Liver Unit- Department of Maternal and Child Health, Roma, Italy;(4)Maggiore Hospital, Paediatric Gastroenterology Unit, Bologna, Italy;(5)University of Verona, Paediatric Clinic- Department of Surgical Sciences- Dentistry- Gynaecology and Paediatrics- Paediatric Division, Verona, Italy;(6)University of Padova, Department of Women’s and Children’s Health, Padova, Italy;(7)Institute for Maternal and Child Health @IRCCS Burlo Garofolo@, Paediatric Gastroenterology, Trieste, Italy;(8)University of Foggia, Pediatrics- Department of Medical and Surgical Sciences, Foggia, Italy;(9)University of Florence, Gastroenterology and Nutrition Unit- Meyer children’s Hospital- Department Neurofarba-, Florence, Italy;(10)Children Hospital- AO SS Antonio e Biagio e C. Arrigo, Pediatric and Paediatric Emergency Unit- “U. Bosio” Centre for Paediatric Digestive Diseases, Alessandria, Italy;(11)University of Naples “Federico II”, Department of Translational Medical Science- Section of Paediatrics, Napoli, Italy;(12)Polytechnic University of Marche- G. Salesi Children's Hospital, Department of Paediatrics, Ancona, Italy;(13)Villa Sofia Cervello Hospital-, Pediatric Unit, Palermo, Italy;(14)“IRCCS Casa Sollievo della Sofferenza”, Division of Paediatrics, San Giovanni Rotondo, Italy;(15)University of Milano Bicocca- Fondazione MBBM- Onlus San Gerardo Hospital, Paediatric Department, Monza, Italy;(16)Ospedale Papa Giovanni, Paediatric Hepatology Gastroenterology and Transplantation, Mlano, Italy;
P386: Predictive models for assessing the response to ustekinumab in Crohn’s disease patientsECCO'22Year: 2022
Authors: Hubert, A.(1);Bottieau, J.(1);Toubeau, J.F.(1);Franchimont, D.(2,3);Vallée, F.(1);Liefferinckx, C.(2,3);
(1)University of Mons, Department of Electrical Engineering, Mons, Belgium;(2)Hôpital Erasme, Department of Gastroenterology, Brussels, Belgium;(3)Université libre de Bruxelles, Laboratory of experimental gastroenterology, Brussels, Belgium;
P387: Rapid Implementation of an Evidence-Based, Virtual COVID-19 Vaccine Education Clinic at the Nova Scotia Collaborative Inflammatory Bowel Disease Clinic (NSCIBD) ProgramECCO'22Year: 2022
Authors: Komeylian, H.(1);Stewart, M.(1);Currie, B.(2);Phalen-Kelly, K.(2);Heisler, C.G.(2);Jones, J.(1);
(1)Dalhousie University, Medicine- Gastroenterology, Halifax, Canada;(2)Nova Scotia Health, Division of Digestive Care & Endoscopy, Halifax, Canada;
P389: Indicators for inadequate response to advanced therapy in patients with Ulcerative Colitis: results from a medical chart review in the United KingdomECCO'22Year: 2022
Authors: Lindsay, J.(1);Picker, N.(2);Kromer, D.(2);Smyth, M.(3);Patel, H.(4);
(1)Barts and the London School of Medicine- Queen Mary University of London, Centre for Immunobiology- Blizard Institute, London, United Kingdom;(2)Ingress Health HWM, GmbH, Wismar, Germany;(3)Galapagos, Uk, Cambridge, United Kingdom;(4)Galapagos, Nv, Mechelen, Belgium;
P390: Efficacy and safety of mesenchymal stem cell therapy with darvadstrocel for complex perianal fistulizing Crohn´s disease: multicentric experience in the Basque Country and NavarreECCO'22Year: 2022
Authors: Elorza, A.(1);Arzallus, T.(2);Izagirre, A.(2);Vicuña, M.(3);Rodriguez, C.(3);Cabriada, J.L.(1);Rodriguez-Lago, I.(1);
(1)Hospital Universitario de Galdakao, Gastroenterology, Galdakao, Spain;(2)Hospital Universitario de Donosti, Gastroenterology, Donosti, Spain;(3)Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain;
P391: Unpacking the different popular diets for pediatric Crohn's disease - concerns around nutritional adequacyECCO'22Year: 2022
Authors: Carmody , E.(1);Haskett , J.(1);Parkinson-McGraw , L.(1);Grover , Z.(1);Martinez , A.(1);Rashid , M.(1);Otley MD MSc FRCPC, A.(1);
(1)IWK Health Centre, Department of Pediatrics, Halifax, Canada;
P393: Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis.ECCO'22Year: 2022
Authors: Veyrard, P.(1);Pellet, G.(2);Laharie, D.(2);Nachury, M.(3);juillerat, P.(4);Altwegg, R.(5);Nancey, S.(6);Fumery, M.(7);Allez, M.(8);Tran minh, M.L.(9);Roblin, X.(10);
(1)CHU SAINT-ETIENNE, Gastroenterology, Saint-Priest-en-Jarez, France;(2)CHU Bordeaux, Gastroenterology, Bordeaux, France;(3)CHU Lille, Gastroenterology, Lille, France;(4)CH Bern Switzerland, Gastroenterology, Bern, Switzerland;(5)University Hospital Montpellier, Gastroenterology, montpellier, France;(6)University Hospital Lyon, Gastroenterology, lyon, France;(7)University hospital Amiens, Gastroenterology, Amiens, France;(8)Saint louis University Hospital, Gastroenterology, paris, France;(9)Saint Louis Universuty Hospital, Gastroenterology, Paris, France;(10)CHU Saint Etienne, Gastroenterology, saint priest en jarez, France;
P394: A prospective analysis of body composition in patients with Inflammatory Bowel Disease and changes during biologic therapyECCO'22Year: 2022
Authors: Nguyen, A.(1);Burns, M.(2);Herath, M.(3);Holt, D.(2);Gibson, P.R.(4);Milat, F.(3);Ebeling, P.(5);Moore, G.(6);
(1)Monash University- Monash Health and Alfred Health, Gastroenterology, Melbourne, Australia;(2)Monash Health, Gastroenterology, Melbourne, Australia;(3)Monash University- Monash Health and Hudson Institute of Medical Research, Endocrinology, Melbourne, Australia;(4)Monash University and Alfred Health, Gastroenterology, Melbourne, Australia;(5)Monash University and Monash Health, Endocrinology, Melbourne, Australia;(6)Monash University and Monash Health, Gastroenterology, Melbourne, Australia;
P395: Proactive Therapeutic Drug Monitoring May Reduce the Need for Combination Therapy in Inflammatory Bowel Disease Patients Treated with InfliximabECCO'22Year: 2022
Authors: Doherty, J.(1);Varley, R.(2);Dunne, C.(2);Mc Carthy, F.(1);Hartery, K.(1);Mc Kiernan , S.(1);Kevans, D.(1);
(1)St James Hospital, Gastroenterology, Dublin, Ireland;(2)St James Hospital, Department of Gastroenterology, Dublin, Ireland;
P398: Long term efficacy and safety of ABP 501 adalimumab biosimilar in inflammatory bowel diseases: preliminary results from the ADASWITCH studyECCO'22Year: 2022
Authors: Cingolani, A.(1);Felice, C.(2);Lombardi, G.(3);Onidi, F.M.(4);Checchin, D.(5);Colucci, R.(6);Grossi, L.(7);Ferronato, A.(8);Rocchi, C.(9);Ascolani, M.(10);Binaghi, L.(4);Dore, M.F.(4);Fanini, L.(11);Bulajic, M.(9);MocciMD FRCP, G.(4);
(1)@Carlo Poma@ Hospital, Gastroenterology and Endoscopy Unit, Mantova, Italy;(2)Medicine 1- Cà Foncello University Hospital, Internal medicine, Treviso, Italy;(3)Azienda ospedaliera univeristaria integrata, Nefrology Unit, Verona, Italy;(4)Gastroenterology Unit- ARNAS G. BROTZU, Internal medicine, Cagliari, Italy;(5)@Ospedale dell'Angelo@- @San Giovanni e Paolo@ Hospital, Gastroenterology Unit, Mestre e Venezia, Italy;(6)@San Matteo degli Infermi@ Hospital, Endoscopy, Spoleto, Italy;(7)@Santo Spirito@ Hospita- @G. D'Annunzio@ University, Gastroenterology Unit, Pescara, Italy;(8)ULSS7 Pedemontana, Digestive Endoscopy Unit, Santorso, Italy;(9)@Mater Olbia@ Hospital, Gastroenterology and GI Endoscopy Unit, Olbia, Italy;(10)Gastroenterology Unit- Cà Foncello University Hospital, General Surgery, Treviso, Italy;(11)Foligno Hospital, Gastroenterology and Endoscopy Unit, Foligno, Italy;
P399: C-Reactive Protein Values After Surgery for Inflammatory Bowel Disease: Is It Still A Good Marker For Intra-Abdominal Complication? A Retrospective Cohort Study of 347 procedures.ECCO'22Year: 2022
Authors: Gaspard, B.(1);Alexandre, C.(1);thibault, V.(1);Lauren, O.(2);Clotilde, D.(1);Najim, C.(1);yann, P.(1);Lefevre, J.(1);
(1)APHP St. Antoine Hospital, Department of General and Digestive Surgery, Paris, France;(2)St Vincent's University Hospital, Department of Colorectal Surgery, Dublin, Ireland;Saint-Antoine IBD Network
P400: Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH studyECCO'22Year: 2022
Authors: Buisson, A.(1);Nachury, M.(2);Reymond, M.(1);Yzet, C.(3);Wils, P.(2);Payen, L.(1);Manlay, L.(1);Pereira, B.(4);Fumery, M.(3);
(1)University Hospital Estaing, Department of Gastroenterology- IBD Unit, Clermont-Ferrand, France;(2)CHRU Lille, IBD Unit, Lille, France;(3)CHU Amiens, IBD Unit, Amiens, France;(4)CHU Clermont-Ferrand, DRCI Biostatistics Unit, Clermont-Ferrand, France;
